Search database
LIST OPTIONS
Filter
11
Filtered Results: 11
Text search: HepBB
Featured
Language
Document type
No document type
6
Studies & Reports
2
Guidelines
2
Strategic & Response Plan
1
Countries / Regions
Zambia
2
Rwanda
2
Global
2
Malawi
1
Botswana
1
Lesotho
1
Authors & Publishers
World Health Organization WHO
3
WHO & UNICEF
2
EMTCT Global Validation Advisory Committee, Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
1
GAVI Alliance
1
Ministry of Health, Zambia
1
UNICEF
1
World Health Organization
1
World Health Organization WHO
1
World Health Organization (WHO)
1
World Health Organization (WHO) & United Nations Children's Fund (UNICEF)
1
Publication Years
Category
Countries
6
Clinical Guidelines
2
Public Health
1
Toolboxes
HIV
1
COVID-19
1
NCDs
1
2016 revision
Accessed 18 June 2018 | Last updated 1-Jun.-2018 (data as of 25-May-2018) | Next overall update Mid-July 2018
2016 revision
Data received as of July 3, 2017 | WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2018
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ... more
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination... more
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... more
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of... more
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig... more